Assessment of the effectiveness and safety of two-month oral supplementation with L-arginine depending on the type of lipid metabolism disorder in patients with atherosclerotic lower limb ischemia.

M Micker, N Balcer-Dymel, M Czerwonka, B Madej, E Swiecka, P A Kolodziejski, E Pruszynska-Oszmalek, Z Checinska-Maciejewska, H Krauss, A Rekas-Dudziak